Aldridge Family Announces Gift to Mayo Clinic
November 28, 2023
Heidi Dieter - Chair-Department of Research Administration, Mayo Clinic Minnesota
Ken and Amy Aldridge - Aldridge Family Foundation
Dr. Quinn P. Peterson, Ph.D. - Senior Associate Consultant in the Department of Physiology and Biomedical Engineering with a joint appointment in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota
Aldridge Electric is excited to announce a new gift in the fight to find a cure for Type 1 Diabetes (T1D). Through the combined efforts of the Kenneth Aldridge Family Foundation and Aldridge Gives, this commitment goes beyond philanthropy. Driven by the passion and dedication of our employees, Aldridge Gives is a heartfelt commitment to empowering, inspiring, and building caring communities. Our mission revolves around championing causes that matter most to us: education, community, health, veterans, and the environment.
In a significant development, the Kenneth Aldridge Family Foundation has partnered with the Mayo Clinic Center for Regenerative Medicine in Rochester, Minnesota to further advance the fight for a T1D cure. The $1.3 million gift has been earmarked for Type 1 Diabetes research, aiming to discover and deliver solutions to the millions of people living with this debilitating disease. T1D has impacted the Aldridge family for the last 18 years. Leading the charge in T1D research at Mayo Clinic is Dr. Quinn P. Peterson, Ph.D.
Ken and Amy Aldridge expressed their admiration for Dr. Peterson, his research team, and Mayo Clinic’s patient-centric approach to medical advancements. "We were impressed by Dr. Peterson, his research team, and Mayo Clinic’s whole person, collaborative approach. They have the ability to take a cure from the lab to bio-manufacturing, and deliver it to the patient, all in house," Ken stated. To learn more about the Peterson Family's powerful T1D story, please click here .
The Aldridge family and Aldridge Electric have a long history of supporting T1D research through the Juvenile Diabetes Research Foundation (JDRF), contributing over $8M since 2004. We will continue to support JDRF.
Aldridge remains resolute in its mission to eradicate T1D, and these partnerships with leading institutions accentuate our commitment to making a difference in the lives of those affected by this challenging disease
